Finance

Lists
VRTX34:BVMF
Vertex Pharmaceuticals Inc BDR
78,00 R$
+0,72%
(+0,56) 1D
7 օգս, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for VRTX34...
Open
78,00 R$
High
78,00 R$
Low
78,00 R$
Mkt. cap
125,73 մլրդ
Avg. vol.
0,00
Volume
1,00
52-wk high
86,31 R$
52-wk low
62,20 R$
Shares outstanding
253,46 մլն
No. of employees
6 հզր
Open
78,00 R$
High
78,00 R$
Low
78,00 R$
Mkt. cap
125,73 մլրդ
Avg. vol.
0,00
Volume
1,00
52-wk high
86,31 R$
52-wk low
62,20 R$
Shares outstanding
253,46 մլն
No. of employees
6 հզր
News stories
From sources across the web
Profile
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. Wikipedia
About Vertex Pharmaceuticals Inc BDR
CEOReshma Kewalramani
Employees6,4 հզր
Founded1989
HeadquartersԲոստոն, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitevrtx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,08 մլրդ
3,19 մլրդ
2,99 մլրդ
3,33 մլրդ
Cost of goods sold
1,39 մլրդ
1,44 մլրդ
1,35 մլրդ
1,48 մլրդ
Cost of revenue
1,39 մլրդ
1,44 մլրդ
1,35 մլրդ
1,48 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
445,10 մլն
487,00 մլն
493,70 մլն
582,20 մլն
Operating expense
445,10 մլն
487,00 մլն
493,70 մլն
582,20 մլն
Total operating expenses
1,84 մլրդ
1,93 մլրդ
1,85 մլրդ
2,07 մլրդ
Operating income
1,24 մլրդ
1,26 մլրդ
1,14 մլրդ
1,27 մլրդ
Other non operating income
14,60 մլն
-14,30 մլն
-6,70 մլն
46,20 մլն
EBT including unusual items
1,30 մլրդ
1,33 մլրդ
1,25 մլրդ
1,39 մլրդ
EBT excluding unusual items
1,35 մլրդ
1,38 մլրդ
1,25 մլրդ
1,42 մլրդ
Income tax expense
215,90 մլն
139,90 մլն
221,50 մլն
292,00 մլն
Effective tax rate
16,62%
10,51%
17,68%
20,98%
Other operating expenses
-
-
-
-
Net income
1,08 մլրդ
1,19 մլրդ
1,03 մլրդ
1,10 մլրդ
Net profit margin
35,20%
37,34%
34,53%
32,99%
Earnings per share
4,80
5,03
4,47
4,73
Interest and investment income
125,70 մլն
121,90 մլն
114,80 մլն
120,60 մլն
Interest expense
-3,30 մլն
-3,30 մլն
-
-
Net interest expenses
122,40 մլն
118,60 մլն
114,80 մլն
120,60 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,29 մլրդ
1,29 մլրդ
1,19 մլրդ
1,33 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps